Arcus Biosciences Inc (RCUS) — Financial Flexibility Index
Arcus Biosciences Inc (RCUS) has a Financial Flexibility Index of -0.29x as of March 2026. Free cash flow of $-138.00 Million (operating CF $-138.00 Million minus capex $0.00) represents 0% of total liabilities ($473.00 Million). Also explore Arcus Biosciences Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arcus Biosciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Arcus Biosciences Inc across 10 annual periods. Check RCUS strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Arcus Biosciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Arcus Biosciences Inc. For the full company profile including market capitalisation, see market value of Arcus Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.94x | $-480.00 Million | $-482.00 Million | $508.00 Million | ▼ -283.1% |
| 2024 | -0.25x | $-164.00 Million | $-170.00 Million | $665.00 Million | ▲ +44.6% |
| 2023 | -0.45x | $-282.00 Million | $-306.00 Million | $633.00 Million | ▼ -169.0% |
| 2022 | 0.65x | $444.00 Million | $438.00 Million | $688.00 Million | ▲ +310.5% |
| 2021 | -0.31x | $-230.09 Million | $-256.17 Million | $750.45 Million | ▼ -172.5% |
| 2020 | 0.42x | $114.22 Million | $111.17 Million | $269.99 Million | ▲ +123.2% |
| 2019 | -1.82x | $-71.54 Million | $-73.46 Million | $39.27 Million | ▼ -85.6% |
| 2018 | -0.98x | $-39.25 Million | $-43.00 Million | $39.98 Million | ▼ -83.9% |
| 2017 | -0.53x | $-19.55 Million | $-25.06 Million | $36.62 Million | ▲ +38.2% |
| 2016 | -0.86x | $-8.85 Million | $-12.94 Million | $10.24 Million | — |